ID   TcOSC-20
AC   CVCL_WW78
DR   Wikidata; Q98133203
RX   PubMed=9119748;
RX   PubMed=12716470;
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3087 ! OSC-20
SX   Female
AG   59Y
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
RX   PubMed=9119748; DOI=10.1111/j.1349-7006.1997.tb00365.x;
RA   Miyazaki A., Sato N., Takahashi S., Sasaki A., Kohama G.-i.,
RA   Yamaguchi A., Yagihashi A., Kikuchi K.;
RT   "Cytotoxicity of histocompatibility leukocyte antigen-DR8-restricted
RT   CD4 killer T cells against human autologous squamous cell
RT   carcinoma.";
RL   Jpn. J. Cancer Res. 88:191-197(1997).
//
RX   PubMed=12716470; DOI=10.1111/j.1349-7006.2002.tb01338.x;
RA   Kondo H., Sahara H., Miyazaki A., Nabeta Y., Hirohashi Y.,
RA   Kanaseki T., Yamaguchi A., Yamada N., Hirayama K., Suzuki M.,
RA   Hamuro J., Torigoe T., Takahashi N., Kohama G.-i., Ikeda H., Sato N.;
RT   "Natural antigenic peptides from squamous cell carcinoma recognized by
RT   autologous HLA-DR8-restricted CD4+ T cells.";
RL   Jpn. J. Cancer Res. 93:917-924(2002).
//